| Product Code: ETC9399101 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea CAR-T Cell Therapy Treatment Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea CAR-T Cell Therapy Treatment Market - Industry Life Cycle |
3.4 South Korea CAR-T Cell Therapy Treatment Market - Porter's Five Forces |
3.5 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Targeted Antigens, 2021 & 2031F |
3.8 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
4 South Korea CAR-T Cell Therapy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in South Korea |
4.2.2 Rising investments in healthcare infrastructure and research |
4.2.3 Growing acceptance of personalized medicine in cancer treatment |
4.3 Market Restraints |
4.3.1 High cost associated with CAR-T cell therapy |
4.3.2 Limited awareness and access to advanced treatment options |
4.3.3 Regulatory challenges in the approval process for new therapies |
5 South Korea CAR-T Cell Therapy Treatment Market Trends |
6 South Korea CAR-T Cell Therapy Treatment Market, By Types |
6.1 South Korea CAR-T Cell Therapy Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Autologous CAR-T Cells, 2021- 2031F |
6.1.4 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Allogeneic CAR-T Cells, 2021- 2031F |
6.2 South Korea CAR-T Cell Therapy Treatment Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By First Generation CAR-T Cells, 2021- 2031F |
6.2.3 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Second Generation Car-T Cells, 2021- 2031F |
6.2.4 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Third Generation CAR-T Cells, 2021- 2031F |
6.2.5 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Fourth Generation CAR-T Cells, 2021- 2031F |
6.3 South Korea CAR-T Cell Therapy Treatment Market, By Targeted Antigens |
6.3.1 Overview and Analysis |
6.3.2 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Solid Tumors, 2021- 2031F |
6.3.3 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Hematologic Malignancies, 2021- 2031F |
6.4 South Korea CAR-T Cell Therapy Treatment Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.4.3 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.4.4 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Tecartus, 2021- 2031F |
6.5 South Korea CAR-T Cell Therapy Treatment Market, By Therapeutic Application |
6.5.1 Overview and Analysis |
6.5.2 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Hematological Malignancies, 2021- 2031F |
6.5.3 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.5.4 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.5.5 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.5.6 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.5.7 South Korea CAR-T Cell Therapy Treatment Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F |
7 South Korea CAR-T Cell Therapy Treatment Market Import-Export Trade Statistics |
7.1 South Korea CAR-T Cell Therapy Treatment Market Export to Major Countries |
7.2 South Korea CAR-T Cell Therapy Treatment Market Imports from Major Countries |
8 South Korea CAR-T Cell Therapy Treatment Market Key Performance Indicators |
8.1 Patient response rates to CAR-T cell therapy |
8.2 Number of clinical trials and research studies in the field |
8.3 Adoption rate of CAR-T cell therapy in cancer treatment centers |
9 South Korea CAR-T Cell Therapy Treatment Market - Opportunity Assessment |
9.1 South Korea CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 South Korea CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 South Korea CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Targeted Antigens, 2021 & 2031F |
9.4 South Korea CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 South Korea CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10 South Korea CAR-T Cell Therapy Treatment Market - Competitive Landscape |
10.1 South Korea CAR-T Cell Therapy Treatment Market Revenue Share, By Companies, 2024 |
10.2 South Korea CAR-T Cell Therapy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here